Lot documentation is pending
We show no result for this exact configuration while its lot-specific report is unavailable.
Browse the COA library
Purity:99.08% by HPLC
In stock 
Package image for the selected configuration.
CJC-1295 no DAC / Ipamorelin 5 mg + 5 mg
A two-component blend containing CJC-1295 no DAC 5 mg and Ipamorelin 5 mg.
Available to verified research accountsExact-SKU documentationLaboratory research use only
The U.S. Food and Drug Administration has not evaluated statements on this site. Stack Research products are not intended to diagnose, treat, cure, or prevent any disease or medical condition.
Lab results for the selected configuration
The published laboratory report covers this exact lot.
- Exact SKU
- STK-CP10
- Lot
- 005
- Laboratory
- Accumark Labs
- Report ID
- MHCU-CDXL
- Sample received
- 2026-02-24
- Published
- July 5, 2026
IdentityConforms
HPLC purity99.08% by HPLC
Measured content11.18 mg measured
Bacterial endotoxin
Sterility
Read the complete laboratory report
Open full report
Open the PDF to read every page in the lot-specific report.
Documentation is pending for this exact SKU
We show no purity, identity, content, or contaminant result until a lot-specific report is available.
About CJC-1295 no DAC / Ipamorelin
The selected publications characterize Ipamorelin as a growth-hormone secretagogue and report receptor-selectivity and rat-model research. No source is presently selected for the CJC-1295 no DAC component, and no cited paper evaluates the combined formulation.
The cited papers discuss named components, not this combined Stack Research formulation. They do not establish the blend's identity, component interaction, stability, purity, performance, or suitability. For lawful in-vitro laboratory or analytical research only. Not for human or veterinary use.
Configuration and documentation
The configuration selected above controls the exact SKU, package image, and lot report shown on this page.
Research-use boundary
This page does not provide dosing, administration, treatment, diagnostic, or human-outcome guidance.
Product specifications
- Available configurations
- 5 mg + 5 mg
- Physical form
- Lyophilized two-component blend
- Composition
- CJC-1295 no DAC 5 mg + Ipamorelin 5 mg
- Molecular formula
- See individual components
- CAS number
- See individual components
- Molecular weight
- See individual components
- Documentation
- Lot-specific COA published for this exact SKU.
Research & literature
The publications below cover Ipamorelin only. They do not evaluate the no-DAC CJC-1295 component or the combined Stack Research formulation.
A paper's findings do not establish the identity, purity, safety, or intended use of this product.
Search PubMed for CJC-1295 no DAC / Ipamorelin (opens in a new tab)- Ipamorelin Ipamorelin, the first selective growth hormone secretagogue. Raun K et al. · European Journal of Endocrinology · 1998 PMID: 9849822 (opens in a new tab)
- Ipamorelin Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Johansen PB et al. · Growth Hormone & IGF Research · 1999 PMID: 10373343 (opens in a new tab)
Mechanism & research background
The selected papers characterize Ipamorelin as a growth-hormone secretagogue and report receptor-selectivity and rat-model research. They do not evaluate the CJC-1295 no DAC component or the combined formulation.
The publications below cover Ipamorelin only. They do not evaluate the no-DAC CJC-1295 component or the combined Stack Research formulation.
Researchers should read each linked paper for its model, methods, and limits. The cited literature does not supply instructions for this product.
Frequently asked questions
Which component is covered by the selected papers?
Ipamorelin. No source is presently selected for the CJC-1295 no DAC component.
Do the papers evaluate the combined blend?
No. They do not test the fixed 5 mg + 5 mg formulation or establish interaction between its components.
Is a lot report available for the selected configuration?
A current lot report covers exact SKU STK-CP10, lot 005, from Accumark Labs.
Does the selected configuration control the report shown?
Yes. Choosing a configuration updates every SKU-specific field and its linked lot report as one set.
Do the cited papers verify this vial?
No. The papers describe independent research. The lab-results section above contains the lot-specific evidence for this Stack Research product.
Do the studies cover the full CJC-1295 no DAC / Ipamorelin formulation?
The publications below cover Ipamorelin only. They do not evaluate the no-DAC CJC-1295 component or the combined Stack Research formulation.
Can this page guide human or veterinary use?
No. Stack Research supplies this product for laboratory research only. This page provides no dosing, administration, treatment, or diagnostic guidance.
Can researchers open the original sources?
Yes. Each citation opens its PubMed record. The search link above opens the complete product-specific query.
More to explore
Browse other products currently listed in the Stack Research catalog.
C-AMYLIN / G1-S
Research peptide blends · 5 mg + 5 mg View product
BPC-157 / TB-500
Research peptide blends · 5 mg + 5 mg / 10 mg + 10 mg View product
GLOW 70
Research peptide blends · 70 mg total View product
KLOW
Research peptide blends · 80 mg total View product
GLP-1 (SE)
Research peptides · 5 mg / 10 mg View product
GLP-2 (TZ)
Research peptides · 10 mg / 30 mg View product
GLP-3 (RT)
Research peptides · 10 mg / 30 mg View product
BPC-157
Research peptides · 5 mg / 10 mg View product
Need documentation for CJC-1295 no DAC / Ipamorelin?
Send the exact SKU and lot so support can trace the applicable product record.